Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by mavericks2020on May 04, 2021 3:50pm
106 Views
Post# 33125302

close the gap a 0.035 and restart too 0.04 up too 0.045 at

close the gap a 0.035 and restart too 0.04 up too 0.045 at13.51 what s that

V:CLAS - CLARITAS PHARMACEUTICALS INC - https://claritaspharma.com 14:58:00 EDT
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
CLAS - V   159.0 0.04 · 0.045 2389.0 0.04     5,777.0 227 178 0.04  0.045  0.035 0.11  0.015 14:19:21 Apr 30 15 min RT 2¢
TSX-V - V 159.0 0.04 · 0.045 2389.0 0.04     4,542.5 181 142 0.04  0.04  0.035 0.11  0.015 14:19:21   15 min
NEO ATS - U   0.045 +0.005 12.5 887.0 32 12 0.04  0.045  0.035   12:54:09   15 min
Alpha - A   0.04     0.3   1        May 03   15 min
Omega - O   0.04     4.0   4 0.04  0.04  0.04   12:02:44   15 min
Pure - P   0.04     0.3   1            15 min
Chi-X - X   0.04     300.0 12 1 0.04  0.04  0.04   10:00:59   15 min
CX2 - H   0.045 +0.005 12.5 6.5 0 5 0.045  0.045  0.045   13:51:19   15 min
CXD - D   0.0425 +0.0025 6.3 30.0 1 1 0.0425  0.0425  0.0425   10:42:38   15 min
TriAct - M   0.04     6.4   11            15 min

 13.51 hour what's that

Recent Trades - Last 10 of 178
Time ET Ex Price Change Volume Buyer Seller Markers
14:31:55 M 0.04   500 80 National Bank 89 Raymond James  
14:19:21 V 0.04   39,000 7 TD Sec 7 TD Sec K
13:51:19 H 0.045 0.005 4,000 79 CIBC 1 Anonymous K
13:51:19 H 0.045 0.005 222 79 CIBC 7 TD Sec E
13:04:28 V 0.04   500 7 TD Sec 68 Leede  
13:04:27 V 0.04   14,000 7 TD Sec 7 TD Sec K
13:02:38 V 0.04   500 79 CIBC 68 Leede  
13:02:38 V 0.04   200 124 Questrade 68 Leede  
13:02:38 V 0.04   8,000 79 CIBC 7 TD Sec K
13:02:38 V 0.04   6,000 124 Questrade 7 TD Sec K
 

 

 

 

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

 
 

 

 

Recent Bulletins News ReleasesIn The NewsOther
Date ET Symbol Price Type Headline
2021-04-30 17:12 C:CLAS 0.04 SEDAR MD & A SEDAR MD & A
2021-04-30 17:02 C:CLAS 0.04 SEDAR Audited Annual Financial Statements SEDAR Audited Annual Financial Statements
2021-04-29 10:58 C:CLAS 0.04 News Release Claritas Pharmaceuticals arranges $250,000 financing
2021-04-21 10:56 C:CLAS 0.05 News Release Claritas hires CMAX to complete R-107 study
2021-04-15 16:11 C:CLAS 0.075 Shares for Debt Claritas Pharma 700,000 shares for debt
2021-04-14 14:34 C:CLAS 0.075 News Release Claritas to acquire R-107 development licence
2021-04-08 19:25 C:CLAS   News Release Kalytera changes name to Claritas Pharmaceuticals
2021-04-08 16:06 C:CLAS   Change Name Claritas Pharmaceuticals name change from Kalytera

 

 
 

 

 
 
 
<< Previous
Bullboard Posts
Next >>